Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression.

Vallacchi V, Vergani E, Camisaschi C, Deho P, Cabras AD, Sensi M, De Cecco L, Bassani N, Ambrogi F, Carbone A, Crippa F, Vergani B, Frati P, Arienti F, Patuzzo R, Villa A, Biganzoli E, Canevari S, Santinami M, Castelli C, Rivoltini L, Rodolfo M.

Cancer Res. 2014 Jan 1;74(1):130-40. doi: 10.1158/0008-5472.CAN-13-1672.

2.

Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.

Walker EB, Miller W, Haley D, Floyd K, Curti B, Urba WJ.

Clin Cancer Res. 2009 Apr 1;15(7):2541-51. doi: 10.1158/1078-0432.CCR-08-2806. Epub 2009 Mar 24.

3.

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW.

Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32. Epub 2012 Mar 9.

4.

Sentinel node identification by scintigraphic methods in cutaneous melanoma.

Dias Moreira R, Altino de Almeida S, Maliska Guimarães CM, Resende JF, Gutfilen B, Barbosa da Fonseca LM.

J Exp Clin Cancer Res. 2005 Jun;24(2):181-5.

PMID:
16110749
5.

Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.

Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP.

PLoS Med. 2005 Sep;2(9):e284. Epub 2005 Sep 6.

6.

Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.

Manca G, Romanini A, Pellegrino D, Borsò E, Rondini M, Orlandini C, Zucchi V, Pasqualetti F, Mariani G.

J Nucl Med. 2008 Nov;49(11):1769-75. doi: 10.2967/jnumed.108.055350. Epub 2008 Oct 16.

7.

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.

Vallacchi V, Camisaschi C, Dugo M, Vergani E, Deho P, Gualeni A, Huber V, Gloghini A, Maurichi A, Santinami M, Sensi M, Castelli C, Rivoltini L, Rodolfo M.

Genes (Basel). 2016 Dec 14;7(12). pii: E124.

8.

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

Mortarini R, Piris A, Maurichi A, Molla A, Bersani I, Bono A, Bartoli C, Santinami M, Lombardo C, Ravagnani F, Cascinelli N, Parmiani G, Anichini A.

Cancer Res. 2003 May 15;63(10):2535-45.

9.

Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.

Speeckaert R, Vermaelen K, van Geel N, Autier P, Lambert J, Haspeslagh M, van Gele M, Thielemans K, Neyns B, Roche N, Verbeke N, Deron P, Speeckaert M, Brochez L.

Eur J Cancer. 2012 Sep;48(13):2004-11. doi: 10.1016/j.ejca.2011.09.007. Epub 2011 Oct 25.

PMID:
22033321
10.

"Stealth" melanoma cells in histology-negative sentinel lymph nodes.

Itakura E, Huang RR, Wen DR, Cochran AJ.

Am J Surg Pathol. 2011 Nov;35(11):1657-65. doi: 10.1097/PAS.0b013e3182322cf7.

11.

Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node.

Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL.

Mod Pathol. 2004 Jul;17(7):747-55.

12.

Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.

Pearl RA, Pacifico MD, Richman PI, Stott DJ, Wilson GD, Grobbelaar AO.

J Exp Clin Cancer Res. 2007 Mar;26(1):109-15.

PMID:
17550139
13.

Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies.

Gutzmer R, Kaspari M, Brodersen JP, Mommert S, Völker B, Kapp A, Werfel T, Kiehl P.

Histopathology. 2002 Dec;41(6):510-8.

PMID:
12460203
14.

Effect of melanoma on immune function in the regional lymph node basin.

Negin B, Panka D, Wang W, Siddiqui M, Tawa N, Mullen J, Tahan S, Mandato L, Polivy A, Mier J, Atkins M.

Clin Cancer Res. 2008 Feb 1;14(3):654-9. doi: 10.1158/1078-0432.CCR-07-1577.

15.

Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.

Ulmer A, Fischer JR, Schanz S, Sotlar K, Breuninger H, Dietz K, Fierlbeck G, Klein CA.

Clin Cancer Res. 2005 Aug 1;11(15):5425-32.

16.

Sentinel lymph node biopsy and melanoma biology.

Essner R.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2320s-2325s. Review.

18.

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes.

Straten Pt, Dahl C, Schrama D, Pedersen LØ, Andersen MH, Seremet T, Bröcker EB, Guldberg P, Becker JC.

Cancer Immunol Immunother. 2006 May;55(5):495-502. Epub 2005 Jul 7.

PMID:
16001163
19.

A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomas.

Samra S, Sawh-Martinez R, Tom L, Colebunders B, Salameh B, Truini C, Ariyan S, Narayan D.

Ann Plast Surg. 2012 Oct;69(4):415-7. doi: 10.1097/SAP.0b013e31824a21af.

PMID:
22964672
20.

Supplemental Content

Support Center